Nu Skin Enterprises (NYSE:NUS – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 0.650-0.750 for the period, compared to the consensus earnings per share estimate of 0.770. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.8 billion. Nu Skin Enterprises also updated its Q4 guidance to $0.19 to $0.29 EPS.
Nu Skin Enterprises Stock Up 1.6 %
NYSE NUS traded up $0.10 during trading hours on Friday, hitting $6.55. The company had a trading volume of 991,684 shares, compared to its average volume of 751,884. Nu Skin Enterprises has a fifty-two week low of $5.95 and a fifty-two week high of $20.75. The company has a market capitalization of $325.54 million, a price-to-earnings ratio of -2.20 and a beta of 1.14. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. The firm’s 50 day moving average is $6.85 and its 200 day moving average is $9.87.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The company had revenue of $439.10 million for the quarter, compared to analysts’ expectations of $431.87 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. The business’s revenue for the quarter was down 12.2% compared to the same quarter last year. Sell-side analysts anticipate that Nu Skin Enterprises will post 0.78 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
Analysts Set New Price Targets
Several brokerages recently issued reports on NUS. StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Wednesday, October 23rd. Citigroup lowered their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd. Finally, DA Davidson reduced their price objective on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research note on Monday, August 12th.
View Our Latest Research Report on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading
- Five stocks we like better than Nu Skin Enterprises
- What is the S&P 500 and How It is Distinct from Other Indexes
- California Resources Stock Could Be a Huge Long-Term Winner
- About the Markup Calculator
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.